Boehringer Ingelheim India Welcomes GST Council’s Tax Reforms for the Healthcare Sector
Boehringer Ingelheim India commends the recent measures announced by the GST Council aimed at reducing tax rates on medicines and life-saving drugs used for treatment of severe chronic diseases, cancer, rare diseases, medical apparatus,…